Atlas Trials

Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer

Clinical trial NCT02303912 · COMPLETED

Trial details

NCT number
NCT02303912
Sponsor
Imperial College Healthcare NHS Trust
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Ovarian Cancer
Start date
2014-11-01
Primary completion
2017-01-23
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.